RRRichtech Robotics Inc.

With CES 2026 happening next week, it feels like a good time to talk robotics stocks. CES usually brings a lot of hype, but it’s also where we get a glimpse of what’s actually coming next in this space.

Two names I’m watching closely are Richtech Robotics $RR and Serve Robotics $SERV. Richtech is showcasing new robots at CES and already has partnerships with $NVDA, targeting multiple industries. Serve is more focused on last-mile food delivery and has existing deals with major delivery platforms.

Curious what other robotics names people are watching and how you see the sector playing out in 2026?

Hunch Buying techniques on the highest percentages will actually loose.  $NFLX $CMG $NKE $TTD $TSLA $IRDM $ACHR $RR $SPY $GDLC $SNPS $NVDA $TGT $FTNT $PLUG $PATH   $MRNA  These are the stocks that right now , which i see based on certain factors, fundamentals and technical prices can be  a ideal investment. 

Portfolio Snapshot – Strategy & Rationale

This portfolio avoids chasing short-term percentage gainers. Positions are built around durable leaders, selective growth, and asymmetric technology bets, with controlled exposure to mega-caps.

Core / Quality Tilt (not over-weighted):

• NFLX, CMG, NKE – Proven execution, pricing power, brand durability

• SNPS, NVDA – Infrastructure beneficiaries of long-cycle AI adoption

• SPY – Market baseline, volatility buffer

Growth & Tech Expansion:

• TTD, FTNT, IRDM – Scalable platforms with recurring revenue and niche dominance

• TSLA – Optionality across energy, autonomy, and manufacturing efficiency

Asymmetric / Emerging Tech:

• ACHR, Richtech Robotics (RR), PLUG, PATH – Early-stage or turnaround plays where downside is defined but upside is non-linear

Thematic / Diversifiers:

• MRNA – Platform biotech with pipeline optionality

• TGT – Cyclical recovery with valuation support

• GDLC – Digital asset exposure without single-coin risk

This is for informational purposes only. Always perform thorough research and consider your financial situation before making investment decisions. Consider revising it with your own advisors based on life events.

 Investments carry risks, and you may lose value, including your principal investment or your investment might become zero.

For long-term investors, $RR recent momentum is amazing. The market may have started to recognize its real value. Getting added to the S&P Global BMI Index is a big deal too, bringing in institutional buying and more visibility. But $RR doesn't pay a dividend yet. However, with improving fundamentals and cash flow, it looks like it could change down the road. What do you think? Should I buy on dips or let it be because I might be interested due to FOMO?